Oracle (NYSE: ORCL) dropped by -2.8% on June 9, 2026, following Anthropic’s release of two new AI models, Claude Fable 5 and Claude Mythos 5, designed for complex knowledge work and coding, reigniting concerns about the “SaaSpocalypse.” This decline added to a ~9.6% drop on June 5, leaving the stock at around $213.68 ahead of Q4 2026 Oracle earnings due June 10.
Additionally, US Central Command confirmed an Apache helicopter was downed near Oman, prompting President Trump to state that the US “must respond” to an Iranian attack. Software stocks are vulnerable to developments that suggest sustained higher interest rates, making them sensitive to geopolitical tensions.
The June 9 decline further highlighted the ‘SaaSpocalypse’ narrative. Anthropic’s earlier release of Claude Cowork in January 2026 had already caused a $285Bn sell-off in software stocks.
With AI agents becoming available at consumer price points, enterprise software’s per-seat economics face significant pressure, a trend echoed by Goldman Sachs in its discussion of concentration risks in AI stocks.
Q4 FY2026 Oracle Earnings: The $553Bn Backlog vs. Negative Free Cash Flow Tension
Oracle’s Q4 fiscal 2026 earnings report, set for June 10, comes amid notable analytical division. On the bullish side, the company’s AI backlog has surged to around $553Bn, indicating strong demand for Oracle Cloud Infrastructure (OCI).
Analysts like Wedbush’s Dan Ives and Mizuho’s Siti Panigrahi expect solid results, with price targets at $400. Conversely, concerns arise from execution risks and negative cash flow as Oracle increases AI data center spending without immediate revenue conversion.
Although OCI revenue grew ~68% year-over-year, overall revenue increased only 14%, leading to a stock decline and concerns that cloud sales growth has peaked.
RBC maintains a cautious $250 target, citing uncertainty around Oracle’s AI investments. The consensus EPS for fiscal 2026 is around $6.81, and any guidance on capex and cash flow will be crucial.
ORCL Stock Brief: Price, Analyst Targets, and Key Metrics
Prior to the Oracle earnings, Oracle (NYSE: ORCL) is trading around $213.68, down approximately 3.1% for the session and roughly 43% below its September 2025 highs following the OpenAI deal.
The stock reflects a significant decline as FCF and revenue growth lag behind Wall Street’s expectations. Analyst consensus is mixed: Guggenheim and Mizuho hold bullish $400 targets, while RBC is more cautious at $250, and Morgan Stanley recently updated its target following the price drop.
Oracle’s high leverage and negative FCF set it apart from peers. Investors are awaiting the Q4 FY2026 earnings report on June 10, focusing on OCI revenue growth, any updates to the OpenAI commitment, and capex and FCF guidance for fiscal 2027, amid concerns about sector valuation.
Comments
Log in or sign up to join the conversation.